Private Equity Acquisitions Reshape Autism Therapy Landscape

The Development

Private equity (PE) firms have significantly increased their footprint in the Applied Behavior Analysis (ABA) therapy sector, acquiring hundreds of autism treatment centers nationwide. A comprehensive study conducted by researchers at Brown University’s School of Public Health identified 574 autism therapy centers across 42 states that are currently owned by private equity firms as of 2024. The majority of these acquisitions, totaling 142 distinct deals, occurred within a concentrated four-year period between 2018 and 2022.

This surge in investor interest marks a notable shift, as PE firms traditionally focused on other healthcare segments. Yashaswini Singh, a health economist and co-author of the study, highlighted that this expansion into pediatric behavioral health presents a unique set of challenges. Unlike other areas of healthcare, autism therapy often serves children predominantly covered by Medicaid programs, which could lead to significant downstream impacts on state budgets if care intensity is altered.

The study, published in JAMA Pediatrics, utilized proprietary databases, public press releases, and manual verification of archived websites to track these transactions, as private equity firms are not mandated to publicly disclose their acquisitions. This research builds on a broader trend of PE investment in disability service providers, with over 1,000 acquisitions of disability and elder care providers reported between 2013 and 2023.

Market Impact

The increasing private equity presence in ABA therapy centers is driven by several factors, most notably the soaring rates of autism diagnoses. The Centers for Disease Control and Prevention (CDC) now estimates that 1 in 31 children are on the autism spectrum, a substantial increase from 1 in 150 in 2000. This growing demand for services, coupled with the potential for profitability, has made the sector attractive to investors.

The Brown University study found that states with higher autism prevalence and those with more flexible insurance coverage limits were particularly attractive targets for private equity ownership. California, Texas, Colorado, Illinois, and Florida were identified as the states with the highest concentration of these acquisitions. This geographical pattern suggests a strategic focus by PE firms on markets with both high demand and favorable reimbursement environments.

However, this trend raises significant concerns among researchers regarding the potential impact on patient care and equitable access. Daniel Arnold, a senior research scientist at Brown’s School of Public Health and another author of the study, expressed worry about the financial incentives inherent in PE ownership. He cautioned that these firms might employ revenue-generating strategies observed in other PE-backed healthcare settings, potentially leading to children receiving more than the clinically appropriate amount of services. Furthermore, there is a concern that such practices could exacerbate existing disparities in access to high-quality ABA services, particularly for underserved populations.

What’s Next

The researchers emphasize that their initial study serves as a foundational step in understanding the complex implications of private equity involvement in autism therapy. Their next phase of research aims to investigate specific outcomes, including how PE ownership influences changes in therapy intensity, medication use, the age at which children receive a diagnosis, and the duration of treatment. These future studies will be crucial for providing a more nuanced understanding of the actual effects on patient care.

While acknowledging the potential for negative consequences, Singh also noted that private investment could, under certain circumstances, expand access to care, which is not inherently negative. The critical need, she explained, is to quantify both the positive and negative impacts to inform policy and practice. This ongoing research will be vital for policymakers, insurance providers, and ABA professionals to navigate the evolving landscape of autism therapy services and ensure that the focus remains on evidence-based, child-centered care.

Fast Facts

Expert Perspective

The emergence of private equity in autism therapy, particularly with children largely insured by Medicaid, presents a distinct and potentially serious challenge to healthcare quality and state budgets.

Source: disabilityscoop.com